Related Experiment Videos
The use of calcipotriol in HIV-related psoriasis
J D Gray1, W Bottomley, A M Layton
1Department of Dermatology, General Infirmary, Leeds, UK.
Clinical and Experimental Dermatology
|September 1, 1992
Abstract:
We report the case of a 28-year-old homosexual man with advanced HIV disease (CDC classification group IV A) who developed erythrodermic psoriasis which responded to calcipotriol, a topical vitamin D analogue. We believe this to be the first reported case of HIV-related psoriasis responsive to this form of treatment. Systemic therapy for HIV-related psoriasis is limited because of immunosuppressive effects. We suggest that calcipotriol may prove to be a useful therapeutic option in these patients.